Clinical Trial Update: MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies [NA]

View source ↗

Summary

The clinical trial MyeloGen investigating germline testing for predisposition to myeloid malignancies has been withdrawn. No further details are provided in thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Myeloid Malignancy, Myeloid Malignancies | NA | Status: WITHDRAWN